3 ms·
There should be a method + requirement to pay royalties back to public funding for basic research, but pharmaceutical companies really bear 99% of the risk and
by llamaimperative 2y ago
There should be a method + requirement to pay royalties back to public funding for basic research, but pharmaceutical companies really bear 99% of the risk and complexity of bringing a drug to market. It's not all that expensive to find molecules that might do something useful, it's obscenely expensive and risky to prove one does something useful.
- gruez 2y ago>There should be a method + requirement to pay royalties back to public funding for basic research, You mean the patent system? The university of california holds patents on CRISPR, for instance.
- llamaimperative 2y agoCRISPR was obviously commercializable, most academic research is quite a bit further from commercialization and some tiny portion ends up being extremely valuable way downstream nonetheless.